Results 131 to 140 of about 38,381 (226)

Probabilistic Lesion Mapping to Optimize Thalamotomy Targets for Focal Hand Dystonia

Annals of Neurology, Volume 99, Issue 5, Page 1227-1238, May 2026.
Objective Focal hand dystonia (FHD) severely impairs task‐specific motor control, yet the optimal surgical target for stereotactic intervention remains uncertain. This study aimed to identify the precise thalamic lesion site associated with symptomatic improvement and to clarify its network connectivity. Methods We retrospectively analyzed 164 patients
Masahiko Nishitani, Shiro Horisawa, Konstantin Butenko, Hiroki Togo, Arun Garimella, William Drew, Melissa Chua, Esraa Shaban, Takakazu Kawamata, Takaomi Taira, Andreas Horn, Michael D. Fox, Takashi Hanakawa   +12 more
wiley   +1 more source

Urodynamics assessment in patients with multiple sclerosis

BJUI Compass, Volume 7, Issue 5, May 2026.
Abstract Objectives The aim of this study is to review initial urodynamics (UDS) findings in patients with multiple sclerosis (MS) related lower urinary tract symptoms, establish where UDS happen in treatment pathways and to evaluate the benefit of video over standard UDS.
Nicholas Faure Walker, Alexandra Bacon, Manisha Teji, Eskinder Solomon, Arun Sahai, Ross Stephens, Emmanuel Okpii, Charlotte Dunford, Sarah Wood, Emily Speck, Ruth Doherty, Angie Rantell, George Araklitis, Lydia Lilis, Tharani Nitkunan, Michelle Carey, Suzanne Biers, Brendan Berry, Mahreen Pakzad, Hashim Hashim   +19 more
wiley   +1 more source

Acute Respiratory Failure From Massive Esophageal Dilatation due to Achalasia

Clinical Case Reports, Volume 14, Issue 5, May 2026.
Massive esophageal dilatation secondary to achalasia resulting in acute hypoxic respiratory failure from cardiopulmonary mass effect. ABSTRACT Massive esophageal dilation from achalasia can cause acute respiratory failure via lung compression. Prompt recognition and urgent esophageal decompression can rapidly reverse hypoxia and be lifesaving.
Frank Epitropoulos, Omar Brijawi, Sumit Sharma   +2 more
wiley   +1 more source

Use of Botulinum Toxin for Esotropia Treatment in Government Hospitals of Bahrain: A Cross-Sectional Study. [PDF]

Cureus
Alamari HM, Bucheery YA.
europepmc   +1 more source

Repurpose an FDA‐Approved Antibody Using DARPin‐Scaffolded Bridge Protein

Chemistry–Methods, Volume 6, Issue 5, May 2026.
The cell line and scalable upstream/downstream process development needed for every new monoclonal antibody are both highly expensive and time‐consuming, significantly increasing the cost of new antibody therapeutics. By contrast, the production of many synthetic binders can be accomplished rapidly and with lower production costs.
Michael Woolley, Joshua D. Bryant, Samuel Vrana, Karuppiah Chockalingam, Zhilei Chen   +4 more
wiley   +1 more source

Post-sleeve gastrectomy weight loss: Role of botulinum toxin and semaglutide injections. [PDF]

Endosc Int Open
Li Z, Zhang S, Nie Y, Wang P, Liu B, Zhou B, Zhang N, Wang S, Chou S, Zhang L, Wang Z, Meng H.   +11 more
europepmc   +1 more source

Inactivation Strategies of Clostridium perfringens in Foods: Current Challenges and Emerging Interventions

Food Frontiers, Volume 7, Issue 3, May 2026.
Clostridium perfringens forms heat‐resistant spores that complicate food safety. Physical methods (thermal processing, HPP, vacuum cooling, ozone treatments) and chemical interventions (natural antimicrobials, phosphates, nitrate/nitrite, organic acids) reduce vegetative cells and spores, though spore resistance remains a major challenge in food and ...
Deepak Subedi, Bharath Mallavarapu, Pranita Patil, Sujitha Bhumanapalli, Sandesh Chapagain, Kham Bahadur Khatri, Milan Kandel, Amit Kumar Singh   +7 more
wiley   +1 more source

Botulinum Toxin: An Unconventional Tool for the Treatment of Depression? [PDF]

Brain Sci
Gambini M, Gurrieri R, Russomanno G, Cecchini G, Mucci F, Carbone MG, Marazziti D.   +6 more
europepmc   +1 more source

Combined Use of Botulinum Toxin A and Profhilo for Upper Face Rejuvenation: A Randomized Clinical Trial

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Hyaluronic acid (HA) and Botulinum toxin A (BTX‐A) treatments are highly regarded for their effectiveness in facial rejuvenation. Aim To investigate whether adding Profhilo enhances the effects of BTX‐A for frontal skin rejuvenation.
Zahra Saffarian, Amirhossein Rahimnia, Ala Ehsani, Kamran Balighi, Amirhoushang Ehsani, Zahra Razavi, Mina Koohian Mohammadabadi, Faezeh khorasanizadeh, Ghazal Ghaffarzadeh, Parvaneh Hatami   +9 more
wiley   +1 more source

From Molecular Cleavage to Clinical Effect: A Probabilistic Field Model of Botulinum Toxin Action. [PDF]

Biology (Basel)
Armenti AF, Armenti F.
europepmc   +1 more source